메뉴 건너뛰기




Volumn 65, Issue 1, 2015, Pages 54-61

EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: Attenuation by NK-1 receptor blockade

Author keywords

aprepitant (Emend); cardiac dysfunction; EGFR tyrosine kinase inhibitor erlotinib (Tarceva); hypomagnesemia; neutrophil activation; NK 1 receptor blocker; total 8 isoprostane

Indexed keywords

3 NITROTYROSINE; 8 ISOPROSTANE; APREPITANT; ERLOTINIB; MAGNESIUM; SUBSTANCE P; SUPEROXIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; MORPHOLINE DERIVATIVE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE;

EID: 84925533890     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000163     Document Type: Article
Times cited : (31)

References (38)
  • 1
    • 9244222261 scopus 로고    scopus 로고
    • Targeted cancer therapy
    • Sawyers C. Targeted cancer therapy. Nature. 2004;432:294-297.
    • (2004) Nature , vol.432 , pp. 294-297
    • Sawyers, C.1
  • 2
    • 33747855481 scopus 로고    scopus 로고
    • Comparing antibody and small-molecule therapies for cancer
    • Imai K, Takaoka A. Comparing antibody and small-molecule therapies for cancer. Nat Rev Cancer. 2006;6:714-727.
    • (2006) Nat Rev Cancer , vol.6 , pp. 714-727
    • Imai, K.1    Takaoka, A.2
  • 3
    • 47249105667 scopus 로고    scopus 로고
    • Erlotinib: An EGF receptor tyrosine kinase inhibitor in non-small-cell lung cancer treatment
    • Schettino C, Bareschino MA, Ricci V, et al. Erlotinib: an EGF receptor tyrosine kinase inhibitor in non-small-cell lung cancer treatment. Expert Rev Respir Med. 2008;2:167-178.
    • (2008) Expert Rev Respir Med , vol.2 , pp. 167-178
    • Schettino, C.1    Bareschino, M.A.2    Ricci, V.3
  • 4
    • 34247224987 scopus 로고    scopus 로고
    • Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: A prospective study
    • Tejpar S, Piessevaux H, Claes K, et al. Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study. Lancet Oncol. 2007;8:387-394.
    • (2007) Lancet Oncol , vol.8 , pp. 387-394
    • Tejpar, S.1    Piessevaux, H.2    Claes, K.3
  • 5
    • 84858695125 scopus 로고    scopus 로고
    • Risk of anti-EGFR monoclonal antibody-related hypomagnesemia: Systematic review and pooled analysis of randomized studies
    • Petrelli F, Borgonovo K, Cabiddu M, et al. Risk of anti-EGFR monoclonal antibody-related hypomagnesemia: systematic review and pooled analysis of randomized studies. Expert Opin Drug Saf. 2012;11:S9-S19.
    • (2012) Expert Opin Drug Saf , vol.11 , pp. S9-S19
    • Petrelli, F.1    Borgonovo, K.2    Cabiddu, M.3
  • 6
    • 79954586068 scopus 로고    scopus 로고
    • Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib
    • Janjigian YY, Azzoli CG, Krug LM, et al. Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib. Clin Cancer Res. 2011;17:2521-2527.
    • (2011) Clin Cancer Res , vol.17 , pp. 2521-2527
    • Janjigian, Y.Y.1    Azzoli, C.G.2    Krug, L.M.3
  • 7
    • 77955640313 scopus 로고    scopus 로고
    • Effects of the EGFR inhibitor erlotinib on magnesium handling
    • Dimke H, van der Wijst J, Alexander TR, et al. Effects of the EGFR inhibitor erlotinib on magnesium handling. J Am Soc Nephrol. 2010;21: 1309-1316.
    • (2010) J Am Soc Nephrol , vol.21 , pp. 1309-1316
    • Dimke, H.1    Van Der Wijst, J.2    Alexander, T.R.3
  • 8
    • 84891360060 scopus 로고    scopus 로고
    • EGFR inhibition induces proinflammatory cytokines via Nox4 HNSCC
    • Fletcher EV, Love-Homan L, Sobhakumari A, et al. EGFR inhibition induces proinflammatory cytokines via Nox4 HNSCC. Mol Cancer Res. 2013;11:1574-1584.
    • (2013) Mol Cancer Res , vol.11 , pp. 1574-1584
    • Fletcher, E.V.1    Love-Homan, L.2    Sobhakumari, A.3
  • 9
    • 79957886927 scopus 로고    scopus 로고
    • Erlotinib-mediated inhibition of EGFR signaling induces metabolic oxidative stress through NOX4
    • Orcutt KP, Parsons AD, Sibenaller ZA, et al. Erlotinib-mediated inhibition of EGFR signaling induces metabolic oxidative stress through NOX4. Cancer Res. 2011;71:3932-3940.
    • (2011) Cancer Res , vol.71 , pp. 3932-3940
    • Orcutt, K.P.1    Parsons, A.D.2    Sibenaller, Z.A.3
  • 10
    • 84868119568 scopus 로고    scopus 로고
    • Tyrosine kinase inhibitor (TKI)-induced cardiotoxicity: Approaches to narrow the gaps between preclinical safety evaluation and clinical outcome
    • Yang B, Papoian T. Tyrosine kinase inhibitor (TKI)-induced cardiotoxicity: approaches to narrow the gaps between preclinical safety evaluation and clinical outcome. J Appl Toxicol. 2012;32:945-951.
    • (2012) J Appl Toxicol , vol.32 , pp. 945-951
    • Yang, B.1    Papoian, T.2
  • 11
    • 84884134230 scopus 로고    scopus 로고
    • Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes
    • Doherty KR, Wappel RL, Talbert DR, et al. Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes. Toxicol Appl Pharmacol. 2013;272:245-255.
    • (2013) Toxicol Appl Pharmacol , vol.272 , pp. 245-255
    • Doherty, K.R.1    Wappel, R.L.2    Talbert, D.R.3
  • 12
    • 84864200196 scopus 로고    scopus 로고
    • The EGFR tyrosine kinase inhibitor tyrphostin AG-1478 causes hypomagnesemia and cardiac dysfunction
    • Weglicki WB, Kramer JH, Spurney CF, et al. the EGFR tyrosine kinase inhibitor tyrphostin AG-1478 causes hypomagnesemia and cardiac dysfunction. Can J Physiol Pharmacol. 2012;90:1145-1149.
    • (2012) Can J Physiol Pharmacol , vol.90 , pp. 1145-1149
    • Weglicki, W.B.1    Kramer, J.H.2    Spurney, C.F.3
  • 13
    • 84887577724 scopus 로고    scopus 로고
    • Mg-supplementation attenuates ritonavir-induced hyperlipidemia, oxidative stress and cardiac dysfunction in rats
    • Mak IT, Kramer JH, Chen X, et al. Mg-supplementation attenuates ritonavir-induced hyperlipidemia, oxidative stress and cardiac dysfunction in rats. Am J Physiol Regul Integr Comp Physiol. 2013;305:R1102-R1111.
    • (2013) Am J Physiol Regul Integr Comp Physiol , vol.305 , pp. R1102-R1111
    • Mak, I.T.1    Kramer, J.H.2    Chen, X.3
  • 14
    • 70349527600 scopus 로고    scopus 로고
    • Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia
    • Weglicki WB, Chmielinska JJ, Kramer JH, et al. Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia. Magnes Res. 2009;22:1-7.
    • (2009) Magnes Res , vol.22 , pp. 1-7
    • Weglicki, W.B.1    Chmielinska, J.J.2    Kramer, J.H.3
  • 15
    • 79251614627 scopus 로고    scopus 로고
    • The role of magnesium deficiency in cardiovascular and intestinal inflammation
    • Weglicki WB, Mak IT, Chmielinska JJ, et al. The role of magnesium deficiency in cardiovascular and intestinal inflammation. Magnes Res. 2012;23:S199-S206.
    • (2012) Magnes Res , vol.23 , pp. S199-S206
    • Weglicki, W.B.1    Mak, I.T.2    Chmielinska, J.J.3
  • 16
    • 77449157660 scopus 로고    scopus 로고
    • AZT-Induced cardiovascular toxicity-attenuation by Mg-supplementation
    • Mak IT, Chmielinska JJ, Kramer JH, et al. AZT-Induced cardiovascular toxicity-attenuation by Mg-supplementation. Cardiovasc Toxicol. 2009;9:78-85.
    • (2009) Cardiovasc Toxicol , vol.9 , pp. 78-85
    • Mak, I.T.1    Chmielinska, J.J.2    Kramer, J.H.3
  • 17
    • 68849118038 scopus 로고    scopus 로고
    • Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia
    • Kramer JH, Spurney C, Iantorno M, et al. Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia. Am J Med Scis. 2009;338: 22-27.
    • (2009) Am J Med Scis , vol.338 , pp. 22-27
    • Kramer, J.H.1    Spurney, C.2    Iantorno, M.3
  • 18
    • 80055108518 scopus 로고    scopus 로고
    • Loss of neutral endopeptidase activity contributes to neutrophil activation and cardiac dysfunction during chronic hypomagnesemia: Protection by substance P receptor blockade
    • Mak IT, Chmielinska JJ, Kramer JH, et al. Loss of neutral endopeptidase activity contributes to neutrophil activation and cardiac dysfunction during chronic hypomagnesemia: protection by substance P receptor blockade. Exp Clin Cardiol. 2011;16:121-124.
    • (2011) Exp Clin Cardiol , vol.16 , pp. 121-124
    • Mak, I.T.1    Chmielinska, J.J.2    Kramer, J.H.3
  • 19
    • 0242405536 scopus 로고    scopus 로고
    • Suppression of neutrophil and endothelial activation by substance P receptor blockade in the Mg-deficient rat
    • Mak IT, Kramer JH, Weglicki WB. Suppression of neutrophil and endothelial activation by substance P receptor blockade in the Mg-deficient rat. Mag Res. 2003;16:91-97.
    • (2003) Mag Res , vol.16 , pp. 91-97
    • Mak, I.T.1    Kramer, J.H.2    Weglicki, W.B.3
  • 20
    • 84875972623 scopus 로고    scopus 로고
    • Cisplatininduced injury of the renal distal convoluted tubule is associated with hypomagnesaemia in mice
    • Van Angelen AA, Glaudemans B, van der Kemp AW, et al. Cisplatininduced injury of the renal distal convoluted tubule is associated with hypomagnesaemia in mice. Nephrol Dial Transplant. 2013;28:879-889.
    • (2013) Nephrol Dial Transplant , vol.28 , pp. 879-889
    • Van Angelen, A.A.1    Glaudemans, B.2    Kemp Van Der, A.W.3
  • 21
    • 84874096811 scopus 로고    scopus 로고
    • The TRPM6/EGF pathway is downregulated in a rat model of cisplatin nephrotoxicity
    • Ledeganck KJ, Boulet GA, Bogers JJ, et al. The TRPM6/EGF pathway is downregulated in a rat model of cisplatin nephrotoxicity. PLoS One. 2013;8:e57016.
    • (2013) PLoS One , vol.8 , pp. e57016
    • Ledeganck, K.J.1    Boulet, G.A.2    Bogers, J.J.3
  • 25
    • 77956194805 scopus 로고    scopus 로고
    • Methionine sulfoxide reductase B1 (MsrB1) recovers TRPM6 channel activity during oxidative stress
    • Cao G, Lee KP, van der Wijst J, et al. Methionine sulfoxide reductase B1 (MsrB1) recovers TRPM6 channel activity during oxidative stress. J Biol Chem. 2010;285:26081-26087.
    • (2010) J Biol Chem , vol.285 , pp. 26081-26087
    • Cao, G.1    Lee, K.P.2    Wijst Van Der, J.3
  • 26
    • 0026733499 scopus 로고
    • Pathobiology of magnesium deficiency: A cytokine/neurogenic inflammation hypothesis
    • Weglicki WB, Phillips TM, Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol. 1992; 263:R734-R737.
    • (1992) Am J Physiol , vol.263 , pp. R734-R737
    • Weglicki, W.B.1    Phillips, T.M.2
  • 27
    • 0029989106 scopus 로고    scopus 로고
    • Role of free radicals and substance P in magnesium deficiency
    • Weglicki WB, Mak IT, Kramer JH, et al. Role of free radicals and substance P in magnesium deficiency. Cardiovasc Res. 1996;31:677-682.
    • (1996) Cardiovasc Res , vol.31 , pp. 677-682
    • Weglicki, W.B.1    Mak, I.T.2    Kramer, J.H.3
  • 28
    • 0037491368 scopus 로고    scopus 로고
    • Dietary Mg-intake influence circulating pro-inflammatory neuropeptide levels and loss of myocardial tolerance to postischemic stress
    • Kramer JH, Mak IT, Phillips TM, et al. Dietary Mg-intake influence circulating pro-inflammatory neuropeptide levels and loss of myocardial tolerance to postischemic stress. Exp Biol Med. 2003;228:665-673.
    • (2003) Exp Biol Med , vol.228 , pp. 665-673
    • Kramer, J.H.1    Mak, I.T.2    Phillips, T.M.3
  • 29
    • 0031301905 scopus 로고    scopus 로고
    • Human monocytes and macrophages express substance P and neurokinin-1 receptor
    • Ho WZ, Lai JP, Zhu XH, et al. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol. 1997;159: 5654-5660.
    • (1997) J Immunol , vol.159 , pp. 5654-5660
    • Ho, W.Z.1    Lai, J.P.2    Zhu, X.H.3
  • 30
    • 84979852034 scopus 로고    scopus 로고
    • Epidermal growth factor receptor-tyrosine kinase inhibition by erlotinib causes hypomagnesemia, oxidative stress and cardiac dysfunction (abstract)
    • Weglicki WB, Mak IT, Chmielinska JJ, et al. Epidermal growth factor receptor-tyrosine kinase inhibition by erlotinib causes hypomagnesemia, oxidative stress and cardiac dysfunction (abstract). FASEB J. 2013;27: 1128.
    • (2013) FASEB J , vol.27 , pp. 1128
    • Weglicki, W.B.1    Mak, I.T.2    Chmielinska, J.J.3
  • 31
    • 0030943255 scopus 로고    scopus 로고
    • NMDA-receptor regulation of substance P release from primary afferent nociceptors
    • Liu H, Mantyh PW, Basbaum AI. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature. 1997;386: 721-724.
    • (1997) Nature , vol.386 , pp. 721-724
    • Liu, H.1    Mantyh, P.W.2    Basbaum, A.I.3
  • 32
    • 0027872354 scopus 로고
    • Molecular and functional diversity of the NMDA receptor channel
    • Mishina M, Mori H, Araki K, et al. Molecular and functional diversity of the NMDA receptor channel. Ann N Y Acad Sci. 1993;707:136-152.
    • (1993) Ann N y Acad Sci , vol.707 , pp. 136-152
    • Mishina, M.1    Mori, H.2    Araki, K.3
  • 33
    • 0027884870 scopus 로고
    • Molecular characterization of NMDA and metabotropic glutamate receptors
    • Masu M, Nakajima Y, Moriyoshi K, et al. Molecular characterization of NMDA and metabotropic glutamate receptors. Ann N Y Acad Sci. 1993; 707:153-164.
    • (1993) Ann N y Acad Sci , vol.707 , pp. 153-164
    • Masu, M.1    Nakajima, Y.2    Moriyoshi, K.3
  • 34
    • 84886395013 scopus 로고    scopus 로고
    • Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension
    • Dehlin HM, Manteufel EJ, Monroe AL, et al. Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension. Int J Cardiol. 2013;168:4643-4651.
    • (2013) Int J Cardiol , vol.168 , pp. 4643-4651
    • Dehlin, H.M.1    Manteufel, E.J.2    Monroe, A.L.3
  • 35
    • 77950042300 scopus 로고    scopus 로고
    • The cardiotoxicity and myocyte damage caused by small molecule anticancer tyrosine kinase inhibitors is correlated with lack of target specificity
    • Hasinoff BB. The cardiotoxicity and myocyte damage caused by small molecule anticancer tyrosine kinase inhibitors is correlated with lack of target specificity. Toxicol Appl Pharmacol. 2010;244:190-195.
    • (2010) Toxicol Appl Pharmacol , vol.244 , pp. 190-195
    • Hasinoff, B.B.1
  • 36
    • 84902445827 scopus 로고    scopus 로고
    • Cancer therapy-induced cardiotoxicity: Basic mechanisms and potential cardioprotective therapies
    • Hahn VS, Lenihan DJ, Ky B. Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies. J Am Heart Assoc. 2014;3:e000665.
    • (2014) J Am Heart Assoc , vol.3 , pp. e000665
    • Hahn, V.S.1    Lenihan, D.J.2    Ky, B.3
  • 37
    • 50949132320 scopus 로고    scopus 로고
    • Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics
    • Chen M, Kerkelä R, Force T. Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics. Circulation. 2008;117:84-95.
    • (2008) Circulation , vol.117 , pp. 84-95
    • Chen, M.1    Kerkelä, R.2    Force, T.3
  • 38
    • 43549105662 scopus 로고    scopus 로고
    • Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC)
    • Metro G, Finocchiaro G, Toschi L, et al. Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC). Rev Recent Clin Trials. 2006;1:1-13.
    • (2006) Rev Recent Clin Trials , vol.1 , pp. 1-13
    • Metro, G.1    Finocchiaro, G.2    Toschi, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.